BTG Pactual Asset Management US’s iShares US Pharmaceuticals ETF IHE Stock Holding History

BTG Pactual Asset Management US’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-87	Closed	-$5.7K	–	284
2025 Q3	$5.7K	Hold	87	–	–	﹤0.01%	239
2025 Q2	$5.7K	Hold	87	–	–	﹤0.01%	241
2025 Q1	$6.14K	Hold	87	–	–	﹤0.01%	264
2024 Q4	$6.05K	Buy	+87	New	+$5.99K	﹤0.01%	274

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

ACM

Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BTG Pactual Asset Management US's IHE Position: Q4 2025 in Review

BTG Pactual Asset Management US sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2025, closing a stake of 87 shares — an estimated $5.7K sold.

BTG Pactual Asset Management US first reported a position in IHE in Q4 2024 and held it in 4 quarters. The position peaked at $6.14K in Q1 2025. 178 funds tracked by Wall St. Rank hold IHE as of Q4 2025.

BTG Pactual Asset Management US reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2025 after selling out during the quarter.
BTG Pactual Asset Management US sold 87 iShares US Pharmaceuticals ETF shares in Q4 2025, an estimated $5.7K.
BTG Pactual Asset Management US first reported a position in iShares US Pharmaceuticals ETF in Q4 2024 and held it in 4 quarters.
BTG Pactual Asset Management US's iShares US Pharmaceuticals ETF position peaked at $6.14K in Q1 2025.
178 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2025.

Based on BTG Pactual Asset Management US's 13F filing for Q4 2025, filed 17 Feb 2026.